Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons

Diabetes predisposes to cognitive decline leading to dementia and is associated with decreased brain NAD(+) levels. This has triggered an intense interest in boosting nicotinamide adenine dinucleotide (NAD(+)) levels to prevent dementia. We tested if the administration of the precursor of NAD(+), ni...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Sci
Asıl Yazarlar: Chandrasekaran, Krish, Choi, Joungil, Arvas, Muhammed Ikbal, Salimian, Mohammad, Singh, Sujal, Xu, Su, Gullapalli, Rao P, Kristian, Tibor, Russell, James William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313029/
https://ncbi.nlm.nih.gov/pubmed/32466541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21113756
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller